News
Key mechanism identified for reducing chronic inflammation in cardiovascular diseases
A breakthrough discovery in understanding how white blood cells move in the body could pave the way for new treatments.

-
Cancer drug for COVID-19
Researchers, including Dr Matt Johansen from the Centenary UTS Centre for Inflammation and Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, have discovered that a cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients.News Type: Research NewsDate -
Professor Hansbro features on the Good Reading podcast
Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, has been interviewed on the Good Reading podcast about his recently published book, ‘The Good Gut Anti-Inflammatory Diet’.News Type: Media coverageDate -
Study shows early changes in immune cells linked to COPD
A new study led by the Centenary Institute and the University of Bonn has revealed new insights into the early stages of chronic obstructive pulmonary disease (COPD), a debilitating respiratory condition characterised by inflammation in the lungs and severe breathing difficulties.News Type: Research NewsDate -
Key mechanism identified for reducing chronic inflammation in cardiovascular diseases
A breakthrough discovery in understanding how white blood cells move in the body could pave the way for new treatments for chronic inflammation-related diseases including cardiovascular diseases, according to a recent study from the Centenary Institute.News Type: Media releaseDate -
Event celebrates ‘The Good Gut Anti-Inflammatory Diet’
The Centenary Institute has celebrated the publication of a new book, 'The Good Gut Anti-Inflammatory Diet’ at a special event, held at the Dymocks Bookstore, Sydney.News Type: CommunityDate -
Good Gut Anti-Inflammatory Diet book released
A new book, ‘The Good Gut Anti-Inflammatory Diet’, has been released by the Centenary Institute, which is full of informative knowledge, recipes and advice to maintain good gut health to control inflammation and to help prevent disease.News Type: InstituteDate -
What are senescent or aged cells?
As we age our cells also age. They lose their normal functions and become resistant to cell death.News Type: DiscoverDate -
Discovery could open door to new COPD treatment
Research led by the Centenary Institute, the University of Technology Sydney and Ghent University Hospital, Belgium has identified a new therapeutic approach for chronic obstructive pulmonary disease (COPD) – the targeting and inhibition of a protein called RIPK1.News Type: Media releaseDate -
Grant supports new COVID-19 nasal vaccine research
Research led by the Centenary Institute and the University of Sydney – focused on the development of a new nasal COVID-19 vaccine – has received close to $1m in grant funding from the NSW COVID-19 Vaccine Acceleration Research Grants Program.News Type: Media releaseDate -
What is the role of the macrophage?
Macrophages are specialised cells from our immune system.News Type: DiscoverDate -
Annual NSW Asthma Meeting held at Centenary
The Centenary UTS Centre for Inflammation has hosted the 16th Annual NSW Asthma Meeting (NAMe) held at the Centenary Institute, 17-18 November 2022.News Type: Research NewsDate -
New nasal vaccine strategy could improve COVID-19 protection
Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.News Type: Media releaseDate